林俊忠 - 中山大学 - 肿瘤防治中心

个人简介

2007年毕业于中山大学中山医学院临床七年制，2015.09-2016.09于美国德州大学MD Anderson癌症中心访问学习，2018.01-2018.06于普宁市人民医院挂职副院长。致力于结直肠癌和胃肠胰神经内分泌肿瘤的综合治疗，擅长结直肠癌微创手术，包括腹腔镜、机器人辅助手术和经肛内镜显微切除等，曾获华南腹腔镜手术比赛冠军。现任全国抗癌协会大肠癌专委会肝转移学组委员，广东省大肠癌专委会青年委员会委员，广东省医疗行业协会微创外科管理分会委员等。承担或参与13个国家或省部级课题，发表SCI论文15篇，总影响因子超过50分，参编4部专业著作。

研究领域

结直肠癌和胃肠胰神经内分泌肿瘤的综合治疗，尤其擅长结直肠癌的微创手术

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1.Zhao YJ, Sun WP, Peng JH, Deng YX, Fang YJ, Huang J, Zhang HZ, Wan DS, Lin JZ and Pan ZZ. Programmed death-ligand 1 expression correlates with diminished CD8+ T cell infiltration and predicts poor prognosis in anal squamous cell carcinoma patients. Cancer management and research. 2018; 10:1-11. 2.Zhao Y, Lin J, Peng J, Deng Y, Zhao R, Sui Q, Lu Z, Wan D and Pan Z. Hepatitis B Virus Infection Predicts Better Survival In Patients With Colorectal Liver-only Metastases Undergoing Liver Resection. Journal of Cancer. 2018; 9(9):1560-1567. 3.Qiu MZ, Pan WT, Lin JZ, Wang ZX, Pan ZZ, Wang FH, Yang DJ and Xu RH. Comparison of survival between right-sided and left-sided colon cancer in different situations. Cancer medicine. 2018; 7(4):1141-1150. 4.Lin J, Peng J, Zhao Y, Luo B, Zhao Y, Deng Y, Sui Q, Gao Y, Zeng Z, Lu Z and Pan Z. Early recurrence in patients undergoing curative resection of colorectal liver oligometastases: identification of its clinical characteristics, risk factors, and prognosis. Journal of cancer research and clinical oncology. 2018; 144(2):359-369. 5.Zhang RX, Lin JZ, Lei J, Chen G, Li LR, Lu ZH, Ding PR, Huang JQ, Kong LH, Wang FL, Li C, Jiang W, Ke CF, Zhou WH, Fan WH, Liu Q, et al. Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC). Journal of cancer research and clinical oncology. 2017; 143(12):2581-2593. 6.Sui Q, Lin J, Peng J, Zhao Y, Deng Y and Pan Z. Local surgical excision versus endoscopic resection for rectal carcinoid: A meta-analysis. Journal of Cancer. 2017; 8(19):3969-3974. 7.Peng J, Lin J, Zeng Z, Wu X, Chen G, Li L, Lu Z, Ding P, Wan D and Pan Z. Addition of oxaliplatin to capecitabine-based preoperative chemoradiotherapy for locally advanced rectal cancer: Long-term outcome of a phase II study. Oncology letters. 2017; 14(4):4543-4550. 8.Peng J, Lin J, Qiu M, Zhao Y, Deng Y, Shao J, Ding P, Zhang H, Wan D, Lu Z and Pan Z. Oncogene mutation profile predicts tumor regression and survival in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and radical surgery. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2017; 39(7):1010428317709638. 9.Deng YX, Lin JZ, Peng JH, Zhao YJ, Sui QQ, Wu XJ, Lu ZH, Gao YH, Zeng ZF and Pan ZZ. Lymphocyte-to-monocyte ratio before chemoradiotherapy represents a prognostic predictor for locally advanced rectal cancer. OncoTargets and therapy. 2017; 10:5575-5583. 10.Peng J, Lin J, Qiu M, Wu X, Lu Z, Chen G, Li L, Ding P, Gao Y, Zeng Z, Zhang H, Wan D and Pan Z. Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancer. Clinics. 2016; 71(8):449-454. 11.Lin JZ, Peng JH, Qdaisat A, Lu ZH, Wu XJ, Chen G, Ding PR, Li LR, Gao YH, Zeng ZF, Wan DS and Pan ZZ. Preoperative chemoradiotherapy creates an opportunity to perform sphincter preserving resection for low-lying locally advanced rectal cancer based on an oncologic outcome study. Oncotarget. 2016; 7(35):57317-57326. 12.Lin J, Peng J, Qdaisat A, Li L, Chen G, Lu Z, Wu X, Gao Y, Zeng Z, Ding P and Pan Z. Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer. Journal of cancer research and clinical oncology. 2016; 142(12):2551-2560. 13.Lin J, Qiu M, Xu R and Dobs AS. Comparison of survival and clinicopathologic features in colorectal cancer among African American, Caucasian, and Chinese patients treated in the United States: Results from the surveillance epidemiology and end results (SEER) database. Oncotarget. 2015; 6(32):33935-33943. 14.Gao YH, Lin JZ, An X, Luo JL, Cai MY, Cai PQ, Kong LH, Liu GC, Tang JH, Chen G, Pan ZZ and Ding PR. Neoadjuvant sandwich treatment with oxaliplatin and capecitabine administered prior to, concurrently with, and following radiation therapy in locally advanced rectal cancer: a prospective phase 2 trial. International journal of radiation oncology, biology, physics. 2014; 90(5):1153-1160. 15.Lin JZ, Zeng ZF, Wu XJ, Wan DS, Chen G, Li LR, Lu ZH, Ding PR and Pan ZZ. Phase II study of pre-operative radiotherapy with capecitabine and oxaliplatin for rectal cancer and carcinoembryonic antigen as a predictor of pathological tumour response. The Journal of international medical research. 2010; 38(2):645-654.